Scotia Capital’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$112K Hold
24,255
﹤0.01% 882
2025
Q4
$121K Sell
24,255
-7
-0% -$36 ﹤0.01% 864
2025
Q3
$123K Buy
24,262
+7
+0% +$31 ﹤0.01% 869
2025
Q2
$105K Sell
24,255
-1,670
-6% -$8.25K ﹤0.01% 829
2025
Q1
$156K Hold
25,925
﹤0.01% 797
2024
Q4
$102K Sell
25,925
-445
-2% -$1.99K ﹤0.01% 819
2024
Q3
$154K Buy
26,370
+445
+2% +$2.19K ﹤0.01% 789
2024
Q2
$112K Sell
25,925
-835
-3% -$4K ﹤0.01% 789
2024
Q1
$126K Sell
26,760
-165
-0.6% -$632 ﹤0.01% 784
2023
Q4
$132K Sell
26,925
-3,722
-12% -$18.2K ﹤0.01% 756
2023
Q3
$167K Buy
30,647
+1,670
+6% +$13.4K ﹤0.01% 721
2023
Q2
$268K Buy
+28,977
New +$245K ﹤0.01% 676

Other funds holding MPT

Scotia Capital's MPT Position: Q1 2026 in Review

Scotia Capital held its Medical Properties Trust (MPT) position steady in Q1 2026 at 24,255 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #882.

Scotia Capital first reported a position in MPT in Q2 2023 and has held it in 12 quarters since. The position peaked at $268K in Q2 2023. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Scotia Capital held 24,255 shares of Medical Properties Trust worth $112K as of Q1 2026.
  • Scotia Capital left its Medical Properties Trust share count unchanged in Q1 2026.
  • Medical Properties Trust made up ﹤0.01% of Scotia Capital's portfolio in Q1 2026, its #882 holding.
  • Scotia Capital first reported a position in Medical Properties Trust in Q2 2023 and has held it in 12 quarters since.
  • Scotia Capital's Medical Properties Trust position peaked at $268K in Q2 2023.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.